Is a viable methodology in recurrent glioblastoma patients to prolong survival at the risk of procedure-related complications and in newly diagnosed patients with the benefit of decreased complications 1).
Theodotou C, Shah AH, Hayes S, Bregy A, Johnson JN, Aziz-Sultan MA, Komotar
RJ. The role of intra-arterial chemotherapy as an adjuvant treatment for
glioblastoma. Br J Neurosurg. 2014 Jan 16. [Epub ahead of print] PubMed PMID:
24432794.